Cancer Charities Exec Stole $187 Million for Personal Use
Donors who have given money to four of the largest cancer charities in the United States may have unknowingly been financing the lavish lifestyle of the C.E.O. who runs them—paying for luxury cruises, elite gym memberships instead of treatment for cancer patients.
That’s according to a suit filed Tuesday by the Federal Trade Commission as well as attorneys general in all 50 states, which alleges that James Reynolds deceived and defrauded donors out of more than $187 million between four of his charities—including the Cancer Fund of America, Cancer Support Services, Children’s Cancer Fund of America and the Breast Cancer Society.
Related: Medicare Recovers Nearly $28 Billion in Fraud Since 1997
The complaint says that the scheme started in the 1980’s. The charities told donors via telemarketing calls that their money would go toward medicine and transportation for cancer patients. However, most of the money actually went toward Reynolds’ personal indulges.
The complaint says that between 2008 and 2012, only three percent of donations actually went to cancer patients.
The FTC also accuses the organizations of cooking their books and reporting inflated revenues as well as “gifts in kind” that they said they distributed internationally.
The FTC said two of the charities—the Children’s Cancer Fund of America and the Breast Cancer Society plan to settle the charges out of court. The Associated Press reported that the Breast Cancer Society, posted a statement on its website Tuesday blaming increased government scrutiny for the charity's downfall.
"While the organization, its officers and directors have not been found guilty of any allegations of wrongdoing, and the government has not proven otherwise, our board of directors has decided that it does not help those who we seek to serve, and those who remain in need, for us to engage in a highly publicized, expensive, and distracting legal battle around our fundraising practices," the statement said.
Several executives who were also involved in the sccheme, including Reynolds’ son, have agreed to a settlement, which bans them from working in fundraising or charities. The two charities that settled, Breast Cancer Society and the Children’ Cancer Fund of America will be dissolved.
The settlement also orders a $65,664,360 judgment, which is the amount consumers donated between 2008 and 2012. Reynolds junior’s judgment will be for suspended once he pays $75,000. Meanwhile the legal proceedings for Reynolds’ senior and the two remaining charities are ongoing.
Tax Refunds Rebound

Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion

The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin

The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane

The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices

The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.